Columbia Technology Ventures
[ Website ]
As Columbia University’s technology transfer organization, Columbia Technology Ventures serves as a bridge between the university’s faculty and researchers, and the business community. Tech Ventures’ core objective is to transfer inventions and innovative knowledge from the University to outside organizations and society at large. Through technology transfer, innovations may be incorporated into products and services that directly benefit people across the globe. The University itself also benefits, as Tech Ventures brings in much-needed revenue, enhancing the quality and breadth of research conducted at Columbia.
Innovations (931):
- Pegylated Apo-A1 for treatment of atherosclerosis in cardiovascular disease (01 SEP 10)
- Novel DNA Methylation Profiling Method (30 AUG 10)
- Ethernet Telephony and Protocols (30 AUG 10)
- Fabrication and Self-assembly of Micromechanical Gears (30 AUG 10)
- Bacterial Spore Germinant (30 AUG 10)
- Generation of antigen-specific T suppressor cells for treatment of rejection and autoimmune diseases (30 AUG 10)
- Methods for generating tolerogenic antigen presenting cells (30 AUG 10)
- Role of PPH1 gene in pulmonary hypertension (30 AUG 10)
- ProcarTM: An improved trocar for laparoscopic surgery (26 AUG 10)
- Non-periodic pulse laser crystallization approach for gen-8 AMOLED TV manufacturing (19 AUG 10)
|
|
Institute Administrator Innovations (0) |
|---|---|
|
|
Institute Administrator Innovations (0) |
|
|
Institute Administrator Innovations (0) |
|
|
Institute Administrator Innovations (0) |
|
|
Institute Administrator Innovations (0) |
|
|
Institute Administrator Innovations (0) |
|
|
Institute Administrator Innovations (913) |
|
|
Case Manager Innovations (0) |
|
|
Case Manager Innovations (0) |
|
|
Case Manager Innovations (0) |
Find more innovations
